Angelica Loskog
Company: Lokon Pharma AB
Job title: CEO
Seminars:
Enhancing T Cell Capacity & Sensitizing Tumors for T Cell Killing by TME Gene Engineering to Enhance ICI & TIL Therapy 9:00 am
• How TME gene engineering can activate, stimulate and attract T and NK cells to the TME though chemokine release and transmigration from blood vessels, invoking antitumor immunity, and enhancing tumor cell immunogenicity • How TME gene engineered vectors can be administered with ICIs to treat solid tumors, supported by clinical data • How TME…Read more
day: Day Two